Related Experiment Video
Updated: Jan 17, 2026

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
Published on: January 26, 2024
Association between serum GDF-15 and hypertension in the third trimester of pregnancy
Cheng Chen1, Qin Li1, Yanxiang Wang2
1Department of Medical Science, Yangzhou Polytechnic College, Yangzhou, Jiangsu Province, China.
Insights
Serum Growth Differentiation Factor 15 (GDF-15) was elevated in pregnant women with hypertensive disorders of pregnancy (HDP). Higher GDF-15 levels correlated with increased blood pressure in these patients.
Area of Science:
- Obstetrics and Gynecology
- Cardiovascular Health
- Biomarkers in Pregnancy
Background:
- Hypertensive disorders of pregnancy (HDP) pose significant risks to maternal and fetal health.
- Understanding the underlying pathophysiology of HDP is crucial for improved management.
- Growth Differentiation Factor 15 (GDF-15) is a cytokine with potential roles in inflammatory and stress responses.
Purpose of the Study:
- To investigate serum Growth Differentiation Factor 15 (GDF-15) expression in third-trimester pregnant women with HDP.
- To examine the correlation between serum GDF-15 levels and blood pressure parameters (systolic and diastolic) in women with HDP.
Main Methods:
- A cross-sectional study design was employed.
- Participants included 60 third-trimester pregnant women diagnosed with HDP and 50 healthy pregnant controls.
- Serum GDF-15 levels were quantified, and clinical characteristics were recorded.
Main Results:
- Serum GDF-15 levels were significantly higher in the HDP group compared to the control group.
- A positive correlation was observed between serum GDF-15 levels and both systolic and diastolic blood pressure in women with HDP.
Conclusions:
- Elevated serum GDF-15 may serve as a potential biomarker in hypertensive disorders of pregnancy.
- GDF-15 levels appear to be associated with the severity of HDP, particularly concerning blood pressure elevation.
Background:
To investigate the expression of serum Growth differentiation factor 15 (GDF-15) and examine its correlation with systolic and diastolic blood pressure in third-trimester pregnant women with hypertensive disorders of pregnancy (HDP).
Methods:
This cross-sectional study included 60 patients with HDP in the third trimester (HDP group) and 50 healthy pregnant women (control group). Clinical characteristics were collected and serum GDF15 levels were measured.
Results:
Serum GDF-15 levels were significantly elevated in the HDP group compared to controls. Moreover, Serum GDF-15 levels were positively correlated with both systolic blood pressure and diastolic blood pressure in the HDP group.
Conclusions:
Serum GDF‑15 levels may be associated with the severity of HDP.
Related Concept Videos
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hormonal Regulation
Hypertension I: Introduction
Hypertension II: Pathophysiology
Hypertension and Regulation of Blood Pressure
Diabetes Mellitus: Type 2 and Gestational

